abagovomab 35
abciximab 37
abituzumab 24
abrilumab 24
actoxumab 18
adalimumab 21
aducanumab 15
afasevikumab 17
alacizumab_pegol 12
alemtuzumab 34
alirocumab 23
amatuximab 46
andecaliximab 28
anifrolumab 22
anrukinzumab 20
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 25
ascrinvacumab 8
atezolizumab 16
atinumab 17
avelumab 15
basiliximab 31
bavituximab 42
begelomab 28
benralizumab 33
bevacizumab_beta 22
bezlotoxumab 18
bimagrumab 23
bleselumab 18
blinatumomab 34
blosozumab 30
bococizumab 21
brazikumab 19
brentuximab_vedotin 37
briakinumab 20
brodalumab 14
brolucizumab 28
brontictuzumab 29
burosumab 22
cabiralizumab 31
camrelizumab 15
canakinumab 24
cantuzumab_ravtansin 50
carlumab 15
carotuximab 29
cergutuzumab_amunaleukin2 31
cergutuzumab_amunaleukin 31
certolizumab_pegol 27
cetiximab 50
citatuzumab_bogatox 30
cixutumumab 32
clivatuzumab_tetraxetan 28
codrituzumab 32
conatumumab 14
concizumab 29
crenezumab 22
crizanlizumab 28
crotedumab 22
dacetuzumab 26
daclizumab 21
dalotuzumab 36
dapirolizumab_pegol 28
daratumumab 14
dectrekumab 10
demcizumab 29
denosumab 10
depatuxizumab 29
depatuxizumab_mafodotin 29
dezamizumab 25
dinutuximab 43
diridavumab 26
domagrozumab 17
drozitumab 24
duligotuzumab 21
durvalumab 13
dusigitumab 22
efalizumab 37
efungumab 31
eldelumab 18
elezanumab 25
elgemtumab 14
elotuzumab 20
emactuzumab 22
emapalumab 31
emibetuzumab 20
enavatuzumab 26
enfortumab_vedotin 15
enoblituzumab 21
enokizumab 26
enoticumab 21
ensituximab 42
eptinezumab 19
erenumab 25
etaracizumab 15
etrolizumab 24
evinacumab 24
evolocumab 23
farletuzumab 8
fasinumab 27
fezakinumab 27
fibatuzumab 13
ficlatuzumab 26
firivumab 38
flanvotumab 24
fletikumab 27
foralumab 15
foravirumab 17
fremanezumab 30
fresolimumab 19
fulranumab 20
futuximab 32
galcanezumab 22
ganitumab 31
gantenerumab 14
gemetuzumab 35
gemtuzumab2 28
gemtuzumab 28
gevokizumab 27
girentuximab 31
glembatumumab 21
glembatumumab_vedotin 21
guselkumab 25
ibalizumab 30
ibritumomab 43
icrucumab 13
idarucizumab 36
ifabotuzumab 13
imalumab 19
imgatuzumab 24
inclacumab 21
indatuximab_ravtansin 38
indusatumab 21
inebilizumab 25
intetumumab 15
iodine_girentuximab 30
ipilimumab 8
iratumumab 15
isatuximab 39
itolizumab 27
ixekizumab 33
labetuzumab_govitecan 26
lambrolizumab 31
lampalizumab 28
lanadelumab 19
landogrozumab 19
laprituximab 33
lebrikizumab 41
lendalizumab 27
lenzilumab 20
lifastuzumab_vedotin 26
ligelizumab 23
lilotomab 42
lirilumab 26
lodelcizumab 21
lokivetmab 25
lorvotuzumab_mertansin 27
lucatumumab 31
lumretuzumab 22
lupartumab 18
lutikizumab 21
margetuximab 37
milatuzumab 41
mirvetuximab 39
mirvetuximab_soravtansin 39
modotuximab 43
mogamulizumab 31
monalizumab 24
motavizumab 39
moxetumomab_pasudotox 34
namilumab 27
naratuximab 34
naratuximab_emtansin 34
narnatumab 17
navicixizumab2 29
navicixizumab 30
navivumab 35
necitumumab 12
nemolizumab 31
nesvacumab 18
nivolumab 14
obiltoxaximab 25
obinutuzumab 36
ocaratuzumab 29
ofatumumab 20
olaratumab 22
olokizumab 26
omalizumab 22
onartuzumab 24
ontuxizumab 37
opicinumab 15
orticumab 17
otelixizumab 39
oxelumab 13
ozanezumab 35
pamrevlumab 13
panobacumab 31
parsatuzumab 30
pasotuxizumab 23
pateclizumab 21
patritumab 27
pembrolizumab 31
perakizumab 25
pidilizumab 25
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 28
polatuzumab_vedotin 22
ponezumab 40
prezalumab 17
pritoxaximab 43
quilizumab 21
racotumomab 33
radretumab 16
ralpancizumab 23
ramucirumab 14
ranevetmab 32
ranibizumab 25
refanezumab 24
remtolumab 21
rilotumumab 18
rinucumab 20
risankizumab 34
rituximab 26
rivabazumab 24
robatumumab 20
roledumab 36
romosozumab 28
rontalizumab 26
rosmantuzumab 25
rozanolixizumab 23
sacituzumab 31
sacituzumab_govitecan 31
samalizumab 29
sapelizumab 24
sarilumab 18
secukinumab 16
seribantumab 18
setoxaximab 50
sifalimumab 15
siltuximab 29
simtuzumab 31
sirukumab 12
solanezumab 28
solitomab 33
stamulumab 24
suptavumab 22
suvizumab 21
tabalumab 18
tadocizumab 22
tamtuvetmab 37
tanezumab 23
tarextumab 13
tavolixizumab 23
telisotuzumab 33
teplizumab 24
tesidolumab 26
tezepelumab 26
tigatuzumab 18
tildrakizumab 24
timolumab 18
tisotumab 15
tosatoxumab 43
tositumomab 40
tralokinumab 32
trastuzumab 24
tregalizumab 24
trevogrumab 14
ublituximab 33
urelumab 22
ustekinumab 30
utomilumab 28
vadastuximab 31
vadastuximab_talirin 31
vandortuzumab_vedotin 22
vantictumab 22
vanucizumab2 22
vanucizumab 31
varlilumab 18
vatelizumab 24
vedolizumab 30
veltuzumab 19
vesencumab 12
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 36
xentuzumab 21
zatuximab 43
